The liver is an important organ for gene therapy by virtue of its critical role in metabolism and its production of large amounts of proteins. For instance, numerous metabolic diseases are caused by a single gene defect resulting in synthesis of defective proteins by the liver; examples include familial hypercholesterolemia, hemophilia, and other enzyme deficiencies. In addition, the liver represents an important target organ for gene therapy treatment of other diseases such as liver cancer, viral hepatitis, and allograft rejection. A variety of gene delivery systems has been developed to transfer genes into the liver. In order to target the liver specifically, recombinant viral vectors have been delivered directly to the afferent vessels of the liver. [1] [2] [3] [4] Viral vectors are highly efficient in gene transfer; however, there are serious concerns about the use of viral vectors. These include the possibility of insertional mutagenesis and the induction of the host immune response. [5] [6] [7] [8] [9] Therefore, the safety concerns regarding viral vectors have prompted numerous efforts to develop nonviral delivery systems.
Among the nonviral techniques, naked DNA has been shown as a safe, simple and inexpensive approach for gene delivery. This technique lacks the associated high cost and technical demands of more complex methods, such as constructing viral vectors or formulating nonviral vectors. Localized hepatic gene expression has been achieved using direct DNA injection into the liver of rats and cats, 10 atic DNA injection appears promising. 12, 13 However, gene expression can only be detected around the injected site. We report here that efficient electro-gene transfer to the liver can be achieved through systemic delivery of plasmid DNA, and high levels of gene expression have been detected in all electroporated areas.
We initially investigated whether more widely spread expression could be achieved through systemic administration compared with local injection. Eighty micrograms of luciferase plasmid in 100 l of normal saline (0.9% NaCl) was injected into mice via tail vein, or the same amount of plasmid in 50 l of normal saline was directly injected into the left median lobe of mouse liver. Electric pulses (250 V/cm, 20 ms per pulse, 8 pulses) were immediately delivered, using a 1-cm 2 tweezertrode (Genetronics, San Diego, CA, USA) to the left median lobe after administration of plasmid DNA. Eight hours after plasmid DNA injection, the mice were killed and the electroporated and injected lobes were divided into four sections. The first section for the local injection included the injection site. As shown in Figure 1 , high level of gene expression was observed only in section one for electroporation following direct injection, and expression decreased approximately 20 to 1000 times in other sections. On the other hand, all sections in the group following intravenous injection displayed high levels of luciferase activity. The data represented in Figure 1b show that the median lobe expressed approximately 8 × 10 8 RLU/mg protein (about 64 ng of luciferase protein per mg of total extracted protein). Other lobes that were not electroporated and other tissues including the stomach, duodenum, pancreas and kidney expressed a limited amount of luciferase protein. However, when electric pulses were delivered to each of these lobes, all lobes expressed high levels of luciferase protein ( Figure  1c) . In other experiments, the influence of electric pulses on gene expression was examined. Luciferase activity increased with increasing electric field strength, and reached a maximal level at 250 V/cm (data not shown). Further increases in the field strength resulted in decreasGene Therapy ing levels of gene expression. This decrease may be due to the damage induced by high field strength. When the field strength was fixed at 250 V/cm, the transgene expression increased with increase in the pulse number, or duration. Luciferase reached a plateau level at the pulse number of 8, or at the pulse duration of 20 ms. Therefore, we refer to this procedure (250 V/cm, 20 ms per pulse, eight pulses) as the standard electro-transfer condition.
DNA dose dependence was investigated in order to maximize gene expression in the liver. Quantities ranging from 20 to 160 g were examined. Luciferase expression was directly proportional to the quantity of DNA injected, with the highest activity observed at 80 g of DNA. The effect of time interval between the injection and electroporation on luciferase expression was also examined (Figure 2a) . The electro-transfer effect was detected when DNA was injected as much as 5 min before the delivery of the electric pulses. However, the level of gene expression dramatically decreased at intervals beyond 5 min, at which time the majority of DNA may be cleared from the circulation. 14 In contrast, when DNA injection was performed 1 min (or later) after the delivery of electric pulses, no increase in foreign gene expression was detected. These results (Figure 2) , together with the results regarding the influence of the electric pulse are in agreement with those studies for muscle electrogene transfer. 15 Time-dependent gene expression shown in Figure 2b indicates that the level of luciferase activity reached a peak level at 8 h, followed by a decline of gene expression. The luciferase activity dropped approximately 50-fold from 8 h to 24 h, and decreased another 90-fold from day 1 to day 15. The luciferase activity at 15 days after injection was 2.4 × 10 4 RLU per mg protein, and this level of luciferase was persistently expressed for at least 60 days.
To determine if electroporation could induce toxic effects on the liver of mice, a comprehensive clinical chemistry profile was assessed 1 day after electrogene transfer. The biochemical assay for liver profile includes protein concentration (total protein and albumin), and concentration of enzymes ALP, AST, ALT and total bilirubin and globulin. Data presented in Table 1 show that there was transient increase in AST and ALT at day 1, and the levels of AST and ALT return to normal by day 5 after gene transfer. The data also indicate that the decrease of ALP is due to the surgery itself and not to electroporation.
Finally, enhancement of gene transfer was tested using LacZ plasmid DNA to elucidate the population and location of cells expressing transgene in the liver. Twelve hours after injection of 100 g of LacZ DNA followed by the electroporation, mice were killed, and the livers were removed for the assay of ␤-galactosidase. Histological analysis in Figure 3 shows approximately 10% of liver cells in the electroporated lobe were positive for expression as indicated by the blue stained cells ( Figure  3 ). ␤-gal staining was observed up to approximately 80% of the depth of the section. The positive cells were mainly hepatocytes. However, ␤-gal-positive staining was also observed around the wall of blood vessels in some sections, which indicates that other cell types were transfected. These cells are yet to be identified.
In summary, in vivo electroporation provides an efficient approach for tissue-targeted local gene expression with a relatively high efficiency of transfection. However, all in vivo electric gene transfer, so far, uses the same strategy, whereby DNA is directly injected into target tissue before electric pulses are delivered to that tissue. One major drawback for the direct injection is that gene expression is only limited to the injection site around the needle track. In this study, we report for the first time that electric gene transfer to the liver could be achieved through systemic administration of plasmid DNA. Luciferase expression and ␤-gal staining show that cells expressing the reporter gene are more broadly distributed with systemic delivery, as compared with direct injection. Such improved method of liver gene transfer may find its applications in gene therapy studies.
